{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:30:30Z","timestamp":1789583430403,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Secretory leukocyte protease inhibitor (SLPI) is an important cationic protein involved in innate airway immunity and highly expressed in mucosal secretions, shown to target and inhibit neutrophil elastase (NE), cathepsin G and trypsin activity to limit proteolytic activity. In addition to the potent anti-protease activity, SLPI has been demonstrated to exert a direct anti-inflammatory effect, which is mediated via increased inhibition and competitive binding of NF-\u03baB, regulating immune responses through limiting transcription of pro-inflammatory gene targets. In muco-obstructive lung disorders, such as Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis (CF), there is an observed elevation in airway SLPI protein concentrations as a result of increased lung inflammation and disease progression. However, studies have identified COPD patients presenting with diminished SLPI concentrations. Furthermore, there is a decrease in SLPI concentrations through cleavage and subsequent inactivation by NE degradation in <jats:italic>Pseudomonas<\/jats:italic> aeruginosa infected people with CF (pwCF). These observations suggest reduced SLPI protein levels may contribute to the compromising of airway immunity indicating a potential role of decreased SLPI levels in the pathogenesis of muco-obstructive lung disease. The Beta Epithelial Na+ Channel transgenic (ENaC-Tg) mouse model phenotype exhibits characteristics which replicate the pathological features observed in conditions such as COPD and CF, including mucus accumulation, alterations in airway morphology and increased pulmonary inflammation. To evaluate the effect of SLPI in muco-obstructive pulmonary disease, ENaC-Tg mice were crossed with SLPI knock-out (SLPI<jats:sup>-\/-<\/jats:sup>) mice, generating a ENaC-Tg\/SLPI<jats:sup>-\/-<\/jats:sup> colony to further investigate the role of SLPI in chronic lung disease and determine the effect of its ablation on disease pathogenesis.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1433642","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T04:52:02Z","timestamp":1725511922000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["SLPI deficiency alters airway protease activity and induces cell recruitment in a model of muco-obstructive lung disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Ryan","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoifa","family":"Dougan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire J.","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian G.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus A.","family":"Mall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwen","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin\u00e9ad","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford C.","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cytogfr.2015.12.001","article-title":"Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response","volume":"28","author":"Majchrzak-Gorecka","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20050768","article-title":"Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding","volume":"202","author":"Taggart","year":"2005","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1128\/iai.64.11.4520-4524.1996","article-title":"Antibacterial activity of antileukoprotease","volume":"64","author":"Hiemstra","year":"1996","journal-title":"Infect Immun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2466-7-1","article-title":"Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): A non-surgical method of lung volume reduction","volume":"7","author":"Strange","year":"2007","journal-title":"BMC Pulm Med"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2018-212895","article-title":"Antimicrobial peptides, disease severity and exacerbations in bronchiectasis","volume":"74","author":"Sibila","year":"2019","journal-title":"Thorax"},{"key":"B6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/thorax.56.1.36","article-title":"Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD","volume":"56","author":"Gompertz","year":"2001","journal-title":"Thorax"},{"key":"B7","first-page":"PA3876","article-title":"Cleaved SLPI as a marker for exacerbation in cystic fibrosis","volume":"46","author":"Twigg","year":"2015","journal-title":"Eur Respir J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8148","DOI":"10.4049\/jimmunol.0901716","article-title":"Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation","volume":"183","author":"Weldon","year":"2009","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1038\/nm1028","article-title":"Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice","volume":"10","author":"Mall","year":"2004","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1233OC","article-title":"Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice","volume":"177","author":"Mall","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044059","article-title":"CFTR regulates early pathogenesis of chronic obstructive lung disease in \u03b2ENaC-overexpressing mice","volume":"7","author":"Johannesson","year":"2012","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.6.4032","article-title":"Potent antimycobacterial activity of mouse secretory leukocyte protease inhibitor","volume":"180","author":"Nishimura","year":"2008","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/biom12121728","article-title":"Secretory Leucoprotease Inhibitor (SLPI) Promotes Survival during Acute Pseudomonas aeruginosa Infection by Suppression of Inflammation Rather Than Microbial Killing","volume":"12","author":"Osbourn","year":"2022","journal-title":"Biomolecules"},{"key":"B14","doi-asserted-by":"crossref","first-page":"1801523","DOI":"10.1183\/13993003.01523-2018","article-title":"Targeting of cathepsin S reduces cystic fibrosis-like lung disease","volume":"53","author":"Small","year":"2019","journal-title":"Eur Respir J"},{"key":"B15","article-title":"Destructive index: a measurement of lung parenchymal destruction in smokers","volume":"131","author":"Saetta","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1136\/thx.22.6.483","article-title":"Internal surface area and other measurements in emphysema","volume":"22","author":"Thurlbeck","year":"1967","journal-title":"Thorax"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2301228","DOI":"10.1183\/13993003.01228-2023","article-title":"Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations","volume":"63","author":"Houston","year":"2024","journal-title":"Eur Respir J"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201311-1932OC","article-title":"Lack of neutrophil elastase reduces inflammation, mucus hypersecretion and emphysema, but not mucus obstruction, in mice with CF-like lung disease","volume":"189","author":"Gehrig","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.18.6692","article-title":"Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase","volume":"83","author":"Thompson","year":"1986","journal-title":"Proc Natl Acad Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2009.00109","article-title":"Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: Implications to cystic fibrosis proteolytic dysfunction","volume":"16","author":"Jackson","year":"2010","journal-title":"Mol Med"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1601328","DOI":"10.1183\/13993003.01328-2016","article-title":"Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease","volume":"49","author":"Persson","year":"2017","journal-title":"Eur Respir J"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2013-0407OC","article-title":"Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12\u2013dependent emphysema","volume":"51","author":"Trojanek","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793%2889%2980657-X","article-title":"Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (\u2018gelatinase\u2019) by human neutrophil elastase and cathepsin G","volume":"249","author":"Okada","year":"1989","journal-title":"FEBS Lett"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00212114","article-title":"Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis","volume":"46","author":"Garratt","year":"2015","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01910-2017","article-title":"Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis","volume":"51","author":"Dittrich","year":"2018","journal-title":"Eur Respir J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6682657","article-title":"Therapeutic inhibition of cathepsin S reduces inflammation and mucus plugging in adult \u03b2ENaC-tg mice","volume":"2021","author":"Brown","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.12.002","article-title":"Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung","volume":"176","author":"Genschmer","year":"2019","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.153560","article-title":"An in vivo model for extracellular vesicle-induced emphysema","volume":"7","author":"Margaroli","year":"2022","journal-title":"JCI Insight"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202303-0471OC","article-title":"Protease-armed, pathogenic extracellular vesicles link smoking and chronic obstructive pulmonary disease","volume":"208","author":"Madison","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.8.5662","article-title":"A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation","volume":"180","author":"Gaggar","year":"2008","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"180017","DOI":"10.1183\/16000617.0017-2018","article-title":"The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease","volume":"27","author":"Patel","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1152\/physiolgenomics.00185.2011","article-title":"Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction","volume":"44","author":"Livraghi-Butrico","year":"2012","journal-title":"Physiol Genomics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"50323","DOI":"10.3791\/50323","article-title":"Investigation of macrophage polarization using bone marrow derived macrophages","author":"Ying","year":"2013","journal-title":"J Vis Exp"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M706884200","article-title":"Secretory leucocyte protease inhibitor inhibits interferon-\u03b3-induced cathepsin S expression","volume":"282","author":"Geraghty","year":"2007","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1433642\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T04:52:11Z","timestamp":1725511931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1433642\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2024.1433642"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1433642","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"article-number":"1433642"}}